Topics

Ebola
Promising Ebola drug protects rhesus monkeys
Promising Ebola drug protects rhesus monkeys

The newly-refined version of a medication that showed early promise against the Ebola virus has proved highly effective in a small group of monkeys infected with the strain of Ebola responsible for the recent epidemic in Western Africa. The experimental treatment, called TKM Ebola, is a version of a biologic medication made by the Canadian firm Tekmira that was administered to infected humans on a compassionate-use basis during the Ebola crisis. The version found effective in rhesus monkeys, however, is a cocktail of small interfering RNAs -- genetically engineered molecules that interfere with a virus' ability to replicate -- that has been tweaked to better match the Ebola strain...

Loading